Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Stockholders' Equity (Deficit)

v3.23.1
Unaudited Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   29,146,367    
Beginning balance at Dec. 31, 2021 $ 57,875 $ 29 $ 317,102 $ (259,256)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation (in shares)   218,345    
Share-based compensation 1,091   1,091  
Net loss available to common stockholders (4,040)     (4,040)
Ending balance (in shares) at Mar. 31, 2022   29,364,712    
Ending balance at Mar. 31, 2022 54,926 $ 29 318,193 (263,296)
Beginning balance (in shares) at Dec. 31, 2022   29,430,267    
Beginning balance at Dec. 31, 2022 21,528 $ 29 320,071 (298,572)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation (in shares)   1,066,881    
Share-based compensation 861   861  
Share issuance 0 $ 1 (1)  
Net loss available to common stockholders (3,484)     (3,484)
Ending balance (in shares) at Mar. 31, 2023   30,497,148    
Ending balance at Mar. 31, 2023 $ 18,905 $ 30 $ 320,931 $ (302,056)